StockTrendNews.com

		US Markets in: hrs min sec

Set StockTrendNews.com as your Homepage! - Click Here

Home About Us Subscribe Contact

StockTrendNews (STN) Exclusive: Amicus Therapeutics Inc

Enter Symbol or Keywords

Latest 12 months Revenue for Amicus Therapeutics is Up 54.99% according to T12-NEWS

Stock Quote: (NGM:FOLD)

11/16/2009

2.53

+0.03

+1.20%

11,248

Latest 12 months Revenue for Amicus Therapeutics is Up 54.99% according to T12-NEWS

Last

Price Change

% Chg

Volume

New York, NY, November 16, 2009,T12-NEWS says that trailing twelve month (TTM) Revenue for Amicus Therapeutics (NASDAQ:FOLD) for its twelve months ended September 30, 2009 increased by 54.99% to $19,2 ... read full story

Website Address:	www.amicustherapeutics.com
Industry:	Bio-Pharma & Therapeutics

Most Recent STN Exclusives

07/30/2010

EBITDA for AirTran Reaches Twelve Year High

07/30/2010

EBITDA for Union Pacific Reaches Sixteen Year High

07/30/2010

Fourteen Year High in EBITDA for Mettler-Toledo

07/30/2010

CA's EBITDA Hits Nine Year High

07/30/2010

EBITDA for Intuitive Surgical Reaches Nine Year High

07/30/2010

StockDiagnostics.com Reiterates Omnicom Group's OPS Ranking of "2"

07/30/2010

Four Year Low in Free Cash Flow for Embotelladora Andina

07/30/2010

Two Year High in Free Cash Flow for Janus Capital

07/30/2010

Free Cash Flow Decreases 91% for Coca-Cola FEMSA

07/30/2010

StockDiagnostics.com Reiterates Safeway's OPS Ranking of "2"

Interactive Chart: FOLD

Flash Player 9 or higher is required to view the chart
Click here to download Flash Player now

More STN Exclusives for: FOLD

05/20/2010

EBITDA for Amicus Therapeutics Reaches Two Year High

05/19/2010

Most recent 12 month Revenue for Amicus Therapeutics Increased by 264.09% as reported by T12-NEWS

05/18/2010

OPS Ranking of "8" for Amicus Therapeutics Reiterated by StockDiagnostics.com

... more FOLD exclusives

Other News Sources: FOLD

07/27/2010

Amicus Therapeutics to Host Its Second Quarter 2010 Financial Results Conference Call and Webcast on August 5, 2010

07/21/2010

Amicus CEO Represents BIO on Rare Diseases at U.S. Senate Committee on Health, Education, Labor and Pensions Bipartisan Hearing

05/06/2010

Alzheimer's Drug Discovery Foundation Funds Amicus Therapeutics To Advance Pharmacological Chaperone Technology

... more FOLD news from other sources

Daily Market Updates

07/30/2010

Stocks End July with Strongest Monthly Gains in a Year

Stocks ended flat and closed July with the strongest monthly gains in a year. The markets were volatile throughout the session following mixed economic data earlier. Recovery concerns were renewed after GDP growth slowed in Q2, but Chicago PMI jumped ... read full story